Motley Fool  Oct 13  Comment 
Because of course everyone wants to pay for what they previously got for free.
New York Times  Oct 12  Comment 
Enabling patients to choose more costly alternatives can result in higher premiums, new research finds.
The Economic Times  Oct 12  Comment 
The focus has been to offer value to consumers through the week, not linked to coupons or free offers, so that the expectation is consistent.
Clusterstock  Sep 29  Comment 
This story was delivered to BI Intelligence "Payments Briefing" subscribers. To learn more and subscribe, please click here. Samsung Pay, which has reached its one-year anniversary in the US, will give in-app users access to Quotient...
FiercePharma  Sep 1  Comment 
Thanks, Mylan. Your EpiPen pricing saga puts pharma’s winning copay coupons under interrogation esagonowsky Thu, 09/01/2016 - 10:15
MedPage Today  Aug 31  Comment 
(MedPage Today) -- Do coupons really make costly drugs more affordable?
TechCrunch  Aug 30  Comment 
 Facebook’s goal of tracking ads all the way through to a customer’s purchase at point-of-sale is getting a big boost today with a makeover of the Facebook Offers program. Now designed to be more mobile-friendly, Facebook is...
MarketWatch  Aug 25  Comment 
Target Corp. said Thursday that it will offer an extra 10% discount on Sunday both in stores and online, a first for the retailer. Coupons will be available in the Sunday weekly ad. Or, starting Friday, shoppers can text the word "Run" to...
NPR  Aug 25  Comment 
EpiPen, the new poster child for prescription drug price gouging, may find that offering discount coupons isn't enough to mollify its critics in Congress and online.
Clusterstock  Aug 25  Comment 
Mylan, the company that sells the lifesaving antiallergy shot EpiPen, has said it will provide discount coupons to patients to subsidize the $600 drug. Mylan also said that it would double the number of people eligible for its patient-assistance...


Related Articles


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki